Genetic immunization against anthrax

被引:50
作者
Galloway, D
Liner, A
Legutki, J
Mateczun, A
Barnewall, R
Estep, J
机构
[1] USN, Med Res Ctr, Biol Def Res Directorate, Silver Spring, MD 20910 USA
[2] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA
[3] Battelle Mem Inst, Columbus, OH 43201 USA
关键词
DNA vaccine; anthrax; B; anthracis;
D O I
10.1016/j.vaccine.2003.09.043
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The objective of this study was to determine whether a DNA prime-protein boost immunization against the Bacillus anthracis protective antigen (PA) and lethal factor (LF) antigens could induce a protective immune response against significant aerosol challenge in the rabbit model. Rabbits were vaccinated with different regimens of DNA vaccines (Table 1) and aerosol challenged with B. anthracis spores, Ames strain, with an average dose of 50 LD50s with a range from 18 to 169 LD50s. Of the five vaccinated rabbits that survived, two were immunized intramuscularly (i.m.) with DNA followed with a protein boost and three were immunized subcutaneous (s.q.) with recombinant protein. A major factor predicting survival was the ability of the animal to mount a lasting antibody response to PA. Rabbit sera were collected prior to and following aerosol challenge and titrated for PA antibodies by indirect ELISA. The results of this study indicate that DNA-based immunization against PA and LF induces significant protective immunity against aerosol challenge in the rabbit model and compares favorably with protein-based immunization. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1604 / 1608
页数:5
相关论文
共 10 条
[1]   Bacillus anthracis, a bug with attitude! [J].
Baillie, L ;
Read, TD .
CURRENT OPINION IN MICROBIOLOGY, 2001, 4 (01) :78-81
[2]   Disruption of anthrax toxin binding with the use of human antibodies and competitive inhibitors [J].
Cirino, NM ;
Sblattero, D ;
Allen, D ;
Peterson, SR ;
Marks, JD ;
Jackson, PJ ;
Bradbury, A ;
Lehnert, BE .
INFECTION AND IMMUNITY, 1999, 67 (06) :2957-2963
[3]   DNA vaccines [J].
Donnelly, JJ ;
Ulmer, JB ;
Shiver, JW ;
Liu, MA .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :617-648
[4]   Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin [J].
Fellows, PF ;
Linscott, MK ;
Ivins, BE ;
Pitt, MLM ;
Rossi, CA ;
Gibbs, PH ;
Friedlander, AM .
VACCINE, 2001, 19 (23-24) :3241-3247
[5]   Vaxfectin enhances the humoral immune response to plasmid DNA-encoded antigens [J].
Hartikka, J ;
Bozoukova, V ;
Ferrari, M ;
Sukhu, L ;
Enas, J ;
Sawdey, M ;
Wloch, MK ;
Tonsky, K ;
Norman, J ;
Manthorpe, M ;
Wheeler, CJ .
VACCINE, 2001, 19 (15-16) :1911-1923
[6]   Molecular pathogenesis of Bacillus anthracis infection [J].
Little, SF ;
Ivins, BE .
MICROBES AND INFECTION, 1999, 1 (02) :131-139
[7]   Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers [J].
McBride, B ;
Mogg, A ;
Telfer, JL ;
Lever, MS ;
Miller, J ;
Turnbull, PCB ;
Baillie, L .
VACCINE, 1998, 16 (08) :810-817
[8]   In vitro correlate of immunity in a rabbit model of inhalational anthrax [J].
Pitt, MLM ;
Little, SF ;
Ivins, BE ;
Fellows, P ;
Barth, J ;
Hewetson, J ;
Gibbs, P ;
Dertzbaugh, M ;
Friedlander, AM .
VACCINE, 2001, 19 (32) :4768-4773
[9]   Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein [J].
Price, BM ;
Liner, AL ;
Park, S ;
Leppla, SH ;
Mateczun, A ;
Galloway, DF .
INFECTION AND IMMUNITY, 2001, 69 (07) :4509-4515
[10]  
TURNBULL PCB, 1988, MED MICROBIOL IMMUN, V177, P293, DOI 10.1007/BF00189414